REITERMANN OUT AS SIEMENS HEALTHINEERS CONTINUES REORGANIZATION
In the wake of the resignation of the president of diagnostics at Siemens Healthineers, Siemens Healthineers CEO Bernd Montag will assume responsibility for the Diagnostics business segment.
Michael Reitermann, president of diagnostics, is leaving his position and will depart the company in September, a Siemens statement said July 31.
The decision seems to be an amicable one reached between Reitermann and the Managing Board of Siemens Healthineers, of which he is a member. In addition to assuming the reins of diagnostics, Montag will also take over enterprise services, customer services business horizontals, and for the regions Americas, Europe, Middle East and Africa and Asia-Pacific.
“Michael Reitermann has demonstrated deep commitment to Siemens as a whole, and Siemens Healthineers in particular, for many years, both in Germany and abroad,” Michael Sen, chairman of the supervisory boards of both Siemens Healthineers AG and Siemens Healthcare GmbH, said in the statement.
“I want to acknowledge his achievements on behalf of the entire supervisory board. He has headed our diagnostics business for many years and helped build the Siemens Healthineers diagnostics franchise out of the three acquisitions of 2006 and 2007. He was a key contributor toward making Atellica Solution an important pillar of our strategy going forward.”
As part of the company’s reorganization, the board has appointed Christoph Zindel, MD and the head of diagnostic imaging at Siemens, as a new member of the board and as the head of the company’s imaging business segment and advanced therapies business segment.
A trained physician with several years of surgical experience, Dr. Zindel has headed diagnostic imaging, the largest business area at Siemens, since 2018. In addition to his work as a physician, Dr. Zindel brings both international experience and experience working in a variety of management positions with Siemens, including in the United States. He will assume his new role Oct. 1.
“In Christoph Zindel, with his extensive experience both in Germany and abroad, we have an outstanding manager who will lead the imaging and advanced therapies businesses into a successful future, also capitalizing on the opportunities offered by digitalization and AI,” Sen said.
Reitermann, who is also responsible for the company’s regional sales and service organization, will step down Sept. 30. VTN